Mobidiag develops and provides industry-leading solutions for in vitro diagnostics of infectious diseases. We make molecular diagnostics fast, accurate and accessible. This improves the quality and efficiency of healthcare, helps prevent the spreading of antibiotic resistances and creates new opportunities for routine diagnostics.
At Mobidiag, we have harnessed our existing technologies and expertise to rapidly develop and supply two coronavirus diagnostics tests providing clinicians with a complete solution suited to their own laboratory needs and capacities. Learn more.
Novodiag® is a turnkey, easy-to-use solution, providing rapid and sensitive on-demand results. The fully automated platform is ideal for complementing high-throughput screening solutions enabling immediate detection of infectious diseases when time-to-result is critical.
Amplidiag® is a family of diagnostic tests for high-volume screening of gastrointestinal pathogens and antibiotic resistances. Amplidiag® Easy takes the suite – unmatched in performance and capability – even further by automating the workflow from primary sample to final result.
